The effects of endoscopic variceal ligation and propranolol on portal hypertensive gastropathy: A prospective, controlled trial

Gastrointestinal Endoscopy

Volumn 53, Issue 6, 2001, Pages 579-584

  Lo, Gin Ho ^a   Lai, Kwok Hung ^a   Cheng, Jeng Shiung ^a   Hsu, Ping I ^a   Chen, Tai An ^a   Wang, E Ming ^a   Lin, Chiun Ku ^a   Chiang, Hung Ting ^a  

^a KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

PROPRANOLOL; VASODILATOR AGENT;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ESOPHAGUS VARICES; FEMALE; FOLLOW UP; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL HEMORRHAGE; HUMAN; LIGATION; MALE; METHODOLOGY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PORTAL HYPERTENSION; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; STOMACH DISEASE;

ADULT; AGED; COMBINED MODALITY THERAPY; ENDOSCOPY, GASTROINTESTINAL; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL HEMORRHAGE; HUMANS; HYPERTENSION, PORTAL; LIGATION; MALE; MIDDLE AGED; PROPRANOLOL; PROSPECTIVE STUDIES; RECURRENCE; STOMACH DISEASES; VASODILATOR AGENTS;

EID: 0035345002     PISSN: 00165107     EISSN: None     Source Type: Journal    
DOI: 10.1067/mge.2001.114062     Document Type: Article

References (34)

1. Quintero E, Pique JM, Bombi JA, Bordas JM, Sentis J, Montserrat E, et al. Gastric mucosal vascular ectasias causing bleeding in cirrhosis. Gastroenterology 1987;93:1054-61.
2. McCormack TT, Sims J, Eyre-Brooke I, Kennedy H, Goepel J, Johnson AG, et al. Gastric lesions in portal hypertension: inflammatory gastritis or congestive gastropathy? Gut 1985;26: 1226-32.
3. Khodadoost J, Katz D, Jervy G. Erosive gastritis: a source of gastrointestinal bleeding in liver cirrhosis [abstract]. Gastroenterology 1971;60:684.
4. Sarin SK, Sreenivas DV, Lahoti D, Saraya A. Factors influencing development of portal hypertensive gastropathy in patients with portal hypertension. Gastroenterology 1992;102: 994-9.
5. Toyonaga A, Iwao T. Portal hypertensive gastropathy. J Gastroenterol Hepatol 1998;13:865-77.
6. Cales P, Zabotto B, Menkens C, Caucans JP, Vinel JP, Desmorat H, et al. Gastroesophageal endoscopic features in cirrhosis. Observer variability, interassociations, and relationship to hepatic dysfunction. Gastroenterology 1990;98:156-62.
7. D'Amico G, Montalbano L, Traina M, Liver Study Group V, Cervello Hospital. Natural history of congestive gastropathy in cirrhosis. Gastroenterology 1990;99:1558-64.
8. Tanoue K, Hashizume M, Wada H, Ohta M, Kitano S, Sugimachi K. Effects of endoscopic injection sclerotherapy on portal hypertensive gastropathy: a prospective study. Gastrointest Endosc 1992;38:582-5.
9. Boldys H, Romanczyk T, Nowak A. Short-term effects of variceal sclerotherapy on portal hypertensive gastropathy. Endoscopy 1996;28:735-9.
10. Stiegmann GV, Goff JS, Michaletz-Onody PA, Korula J, Lieberman D, Saeed ZA, et al. Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices. N Engl J Med 1992;326:1527-32.
11. Lo GH, Lai KH, Cheng JS, Hwu JH, Chang CF, Chen SM, et al. A prospective, randomized trial of sclerotherapy versus ligation in the management of bleeding esophageal varices. Hepatology 1995;22:466-71.
12. Hou MC, Lin HC, Chen CH, Kuo BIT, Perng CL, Lee FY, et al. Changes in portal hypertensive gastropathy after endoscopic variceal sclerotherapy or ligation: an endoscopic observation. Gastrointest Endosc 1995;42:139-44.
13. Yoshikawa I, Murata I, Nakano S, Otsuki M. Effects of endoscopic variceal ligation on portal hypertensive gastropathy and gastric mucosal blood flow. Am J Gastroenterol 1998;93:71-4.
14. Hosking SW, Kennedy HJ, Seddon I, Triger DR. The role of propranolol in congestive gastropathy of portal hypertension. Hepatology 1987;7:437-41.
15. Perez-Ayuso RM, Pique JM, Bosch J, Panes J, Gonzalez A, Perez R, et al. Propranolol in prevention of recurrent bleeding from severe portal hypertensive gastropathy in cirrhosis. Lancet 1991;337:1431-4.
16. Pugh RNN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of esophagus for bleeding esophageal varices. Br J Surg 1973;60:646-9.
17. Beppu K, Inokuchi K, Koyanagi N, Nakayama S, Sakata H, Kitano B, et al. Prediction of variceal hemorrhage by esophageal endoscopy. Gastrointest Endosc 1981;27:213-8.
18. Ohta M, Hashizume M, Higashi H, Ueno K, Tomikawa M, Kishihara F, et al. Portal and gastric mucosal hemodynamics in cirrhotic patients with portal-hypertensive gastropathy. Hepatology 1994;20:1432-6.
19. Iwao T, Toyonaga A, Ikegami M, Oho K, Sumino M, Harada H, et al. Reduced gastric mucosal blood flow in patients with portal hypertensive gastropathy. Hepatology 1993;18:36-40.
20. Marco J, Diego J, Villanueva ML, Diaz-Fierros M, Valverde I, Segovia JM. Elevated plasma glucagon levels in cirrhosis of the liver. N Engl J Med 1973;289:1107-11.
21. Casadevall M, Panes J, Pique JM, Marroni N, Bosch J, Whittle BJR. Involvement of nitric oxide and prostaglandins in gastric mucosal hyperemia of portal-hypertensive anaesthetized rats. Hepatology 1993;18:628-34.
22. Benoit J, Womack RA, Korthius RJ, Wilborn WH, Granger DN. Chronic portal hypertension: effects of gastrointestinal flow distribution. Am J Physiol 1986;250:535-9.
23. Iwao T, Toyonaga A, Sumino M, Takagi K, Oho K, Nishizono M, et al. Portal hypertensive gastropathy in patients with cirrhosis. Gastroenterology 1992;102:2060-5.
24. Laine L. Ligation: endoscopic treatment of choice for patients with bleeding esophageal varices? [editorial]. Hepatology 1995;22:663-5.
25. Lo GH, Liang HL, Lai KH, Chang CF, Hwu JH, Chen SM, et al. The impact of endoscopic variceal ligation on the pressure of the portal venous system. J Hepatol 1996;24:74-80.
26. Nakayama M, Iwao T, Oho K, Toyonaga A, Tanikawa K. Role of extravariceal collateral channels in the development of portal hypertensive gastropathy before and after sclerotherapy. J Gastroenterol 1998;33:142-6.
27. Triger DR. Natural history and treatment of portal hypertensive gastropathy. J Gastroenterol Hepatol 1989;4(suppl 1):8-14.
28. Sarfeh IJ, Juler GL, Stemmer EA, Mason GR. Results of surgical management of hemorrhagic gastritis in patients with gastroesophageal varices. Surg Gynecol Obstet 1982;155: 167-70.
29. Orloff MJ, Orloff MS, Orloff SL, Haynes KS. Treatment of bleeding from portal hypertensive gastropathy by portocaval shunt. Hepatology 1995;21:1011-7.
30. Urata J, Yamashita Y, Tsuchigame T, Hatanaka Y, Matsukawa T, Sumi S. The effects of transjugular intrahepatic portosystemic shunt on portal hypertensive gastropathy. J Gastroenterol Hepatol 1998;13:1061-7.
31. Bosch J, Mastai R, Kravetz D, Bruis J, Gaya J, Rigau J, et al. Effects of popranolol on azygos blood flow and hepatic and systemic hemodynamics in cirrhosis. Hepatology 1984;4:1200-5.
32. Pizcueta MP, Lacy AM, Kravetz D, Bosch J, Rodes J. Propranolol decreases portal-pressure without changing portal-collateral resistance in cirrhotic rats. Hepatology 1989; 10:953-8.
33. Westaby D, Melia W, Hegarty J, Gimson AES, Stellon AJ, Williams R. Use of propranolol to reduce the rebleeding rate during injection sclerotherapy prior to variceal obliteration. Hepatology 1986;6:673-5.
34. Vinel JP, Lamouliatte H, Cales P, Combis JM, Roux D, Desmorat H, et al. Propranolol reduces the rebleeding rate during endoscopic sclerotherapy before variceal obliteration. Gastroenterology 1992;102:1760-3.